This week’s Daily Pulse walks through one of the strongest bank rallies Singapore has seen in a while, with DBS, OCBC and UOB all punching out fresh highs and dragging the Straits Times Index up with them. Angela brings the human angle, her husband cheering a big DBS week, while I stay pinned to the numbers that matter for someone using CPF and SRS for income.
We separate the growth story the analysts are upgrading, from the income story your portfolio actually lives on, and show how every leg higher in price quietly makes fresh entries harder for a yield-focused investor.
We also flag smaller movers, from UOB Kay Hian and PanUnited on the upside to First Resources and the tech names on the downside, plus two MAS proposals that could widen the future toolkit for retail portfolios without changing this week’s stock picture.
Key takeaways:
DBS, OCBC and UOB all hit new highs, powering a 4.29% STI jump for the week.
At S$70.45 DBS and S$27.43 OCBC, new buyers lock in thinner income than a month ago.
Macquarie and Citi upgrades lift price targets into the S$70–S$45 range, but speak to growth, not immediate cashflow.
UOB’s double digit weekly move still sits in a “wait for earnings” bucket, with no forensic verdict before the 7 August numbers land.
MAS’ consultation on alternative funds and new corporate structures could eventually add futures-based commodity funds and single country bond funds to retail menus.
Iggy’s Forensic Disclaimer
This content is produced for educational and informational purposes only. I am not a financial advisor — I am a retail investor who applies forensic analysis to my own portfolio and shares that process publicly. Nothing here constitutes a recommendation to buy, sell, or hold any security, and no specific target prices or personalised financial advice are offered. Stocks assessed under Iggy’s Forensic Yield Standard are benchmarked against a 4.7% minimum yield hurdle; stocks flagged as Growth Watch fall below this threshold but demonstrate clean balance sheet metrics and an identifiable growth catalyst — these carry a materially different risk profile and are not suitable as yield replacements for income-dependent investors. All data is sourced from public filings and verified sources; where data is unverified it is explicitly flagged. All investments carry risk, including the potential loss of principal, and past performance is not indicative of future results. If you are making investment decisions involving CPF, SRS, or personal capital, please conduct your own due diligence or consult a MAS-licensed financial adviser before committing funds.
